20.109(F11): Jamal Elkhader and Colin Beckwitt: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
(New page: =Brief project overview= Biodegradable nanoparticles delivering cancer therapy specifically to prostate tumors via binding to a receptor specific to those cells. Will talk about applying t...) |
No edit summary |
||
Line 1: | Line 1: | ||
=Brief project overview= | =Brief project overview= | ||
Biodegradable nanoparticles delivering cancer therapy specifically to prostate tumors via binding to a receptor specific to those cells. Will talk about applying this procedure to other types of cancer cells and other cells in general - for instance, treating autoimmune disease victims with a nanoparticle bound to EGF that specifically targets bone marrrow. | Biodegradable nanoparticles delivering cancer therapy specifically to prostate tumors via binding to a receptor specific to those cells. Will talk about applying this procedure to other types of cancer cells and other cells in general - for instance, treating autoimmune disease victims with a nanoparticle bound to EGF that specifically targets bone marrrow. | ||
=Background/References:= | =Background/References:= | ||
http://web.mit.edu/newsoffice/2010/nanoparticle-chemotherapy-1005.html | http://web.mit.edu/newsoffice/2010/nanoparticle-chemotherapy-1005.html | ||
http://www.pnas.org/content/early/2010/09/30/1011368107 | http://www.pnas.org/content/early/2010/09/30/1011368107 | ||
http://web.mit.edu/press/2011/cancer-particles.html | http://web.mit.edu/press/2011/cancer-particles.html | ||
Revision as of 21:24, 28 November 2011
Brief project overview
Biodegradable nanoparticles delivering cancer therapy specifically to prostate tumors via binding to a receptor specific to those cells. Will talk about applying this procedure to other types of cancer cells and other cells in general - for instance, treating autoimmune disease victims with a nanoparticle bound to EGF that specifically targets bone marrrow.
Background/References:
http://web.mit.edu/newsoffice/2010/nanoparticle-chemotherapy-1005.html